NSE shareholding pattern
Emcure Pharmaceuticals L shareholding pattern
As of the Jun 2026 shareholding pattern, filed 2026-06-30, promoters held 77.83%, FIIs 4.87%, and DIIs 8.46% of Emcure Pharmaceuticals L (EMCURE). In the Mar 2026 pattern the same figures were promoter 77.87%, FII 3.35% and DII 6.1%. Promoter holding changed between the two filings, so the percentages moved for every category and the difference is not a count of shares bought or sold. The table below shows how promoter, FII, DII and public holding has moved quarter by quarter, taken from the NSE shareholding pattern.
Definition
A shareholding pattern is the quarterly breakdown of who owns a listed company, split across promoters, foreign institutional investors (FII), domestic institutional investors (DII), and the public. Indian companies file it every quarter under SEBI listing rules. Source: NSE shareholding pattern.
Emcure Pharmaceuticals L shareholding by quarter
| Quarter | Promoter % | FII % | DII % | Public % | Filed |
|---|---|---|---|---|---|
| Jun 2026 | 77.83 | 4.87 | 8.46 | 8.84 | 2026-06-30 |
| Mar 2026 | 77.87 | 3.35 | 6.1 | 12.68 | 2026-03-31 |
| Dec 2025 | 77.87 | 3.59 | 6.1 | 12.44 | 2025-12-31 |
| Sep 2025 | 77.88 | 3.29 | 4.36 | 14.47 | 2025-09-30 |
| Jun 2025 | 77.91 | 2.86 | 2.84 | 16.39 | 2025-06-30 |
Disclosures shown are public regulatory filings. Data may be delayed or incomplete. Smart-money entities may no longer hold positions shown. Not investment advice.
Disclosure overlap on Emcure Pharmaceuticals L
14 independent managers14 independent managers disclosed positions in Emcure Pharmaceuticals L within the same window (May 4, 2026 – Aug 2, 2026), per filings across sources. Who they are — and each underlying filing — is shown inside Flock.
A count of what was filed, per public regulatory filings. Not investment advice.
Related on Flock
- Smart money moves this filing week (insider trades, bulk deals and stake disclosures from the last 7 days)
- All NSE shareholding patterns (browse every company by name)
- What is a 13F filing? (how the US equivalent disclosure works)
- FII and DII activity, sourced and dated
- Today's NSE and BSE bulk and block deals
- When smart money's filings overlap (multi-entity disclosure overlap, explained)
Frequently asked questions
What is the promoter holding in Emcure Pharmaceuticals L?
As of the Jun 2026 shareholding pattern, promoters held 77.83% of Emcure Pharmaceuticals L (EMCURE). Figures are taken from the NSE shareholding pattern filing dated 2026-06-30 and may change each quarter. Not investment advice.
What is the FII holding in Emcure Pharmaceuticals L?
Foreign institutional investors held 4.87% of Emcure Pharmaceuticals L as of the Jun 2026 pattern, versus 3.35% in the Mar 2026 pattern. Promoter holding changed between the two filings, so both are levels rather than a change in holding. Source: NSE shareholding pattern, filed 2026-06-30. Not investment advice.
How often is the shareholding pattern updated?
Listed Indian companies disclose their shareholding pattern every quarter under SEBI's listing rules. Flock re-stamps each page when a new quarterly pattern is filed, so the freshness chip reflects the true age of the latest data.
The Smart Money Digest
A free weekly email of notable disclosure activity — every line with its filing date and source link. No advice, just filings. Unsubscribe anytime.